搜索临床试验以:AMO-02-MD-2-003
总计125305个结果
-
Azura OphthalmicsThe University of New South Wales完全的
-
NYU Langone HealthWashington University School of Medicine终止同意接受腹腔镜胃束带手术以减轻体重并同意参与本研究的患者 BMI ≥35 kg/m2 | 使用口服药物和/或仅饮食疗法治疗确诊的 2 型糖尿病 | 18-64岁美国
-
Sanofi Pasteur, a Sanofi Company完全的
-
VA Office of Research and DevelopmentNational Eye Institute (NEI); SmithKline Beecham完全的
-
Stanford University完全的
-
Erasme University HospitalFonds de la Recherche Scientifique (fnrs)尚未招聘
-
Shanghai Yao Yuan Biotechnology Ltd. (also known...尚未招聘
-
Universitaet InnsbruckUniversity of Erlangen-Nürnberg完全的
-
Frontera TherapeuticsPeking Union Medical College Hospital; The First Affiliated Hospital of Zhengzhou University; Tianjin...招聘中
-
Frontera TherapeuticsPeking Union Medical College Hospital; The First Affiliated Hospital of Soochow University; The... 和其他合作者尚未招聘新生血管性年龄相关性黄斑变性
-
Octapharma完全的
-
Arizona State UniversityNational Institutes of Health (NIH); National Center for Complementary and Integrative Health...完全的
-
PfizerJANSSEN Alzheimer Immunotherapy Research & Development, LLC完全的
-
Sanofi Pasteur, a Sanofi Company完全的
-
Pfizer完全的肺部疾病,慢性阻塞性澳大利亚, 英国, 阿根廷, 德国, 印度
-
EyeGene Inc.Novotech (Australia) Pty Limited完全的
-
Ironwood Pharmaceuticals, Inc.Allergan Sales, LLC完全的
-
Immune System Key LtdUniversity of Miami Sylvester Comprehensive Cancer Center招聘中